Spermidine + nicotinamide + palmitoylethanolamide + oleoylethanolamide
1 paper3 findings
- 1 lab in 1 country
- Funder: National Institute of Food and Agriculture
- Human trial1
Outcomes
3Oxidative stress and ROS signalling
downin humans1
1 study
Oxidative stress and ROS signalling
downin humans1
Spermidine + nicotinamide + palmitoylethanolamide + oleoylethanolamide decreases oxidative stress and ROS signalling in humans.
“Net incremental area under the curve for tumor necrosis factor alpha and reactive oxygen species in stimulated macrophages decreased when incubated with plasma following supplement intake (P < .05).”
Human trialin stimulated macrophages incubated with plasmamalesn = 5
Nutrition research (New York, N.Y.)Oct 23, 2024
TNF-alpha
downin humans1
1 study
TNF-alpha
downin humans1
Spermidine + nicotinamide + palmitoylethanolamide + oleoylethanolamide decreases TNF-alpha in humans.
“Net incremental area under the curve for tumor necrosis factor alpha and reactive oxygen species in stimulated macrophages decreased when incubated with plasma following supplement intake (P < .05).”
Human trialin stimulated macrophages incubated with plasmamalesn = 5
Nutrition research (New York, N.Y.)Oct 23, 2024
1-methylnicotinamide
upin humans1
1 study
1-methylnicotinamide
upin humans1
Spermidine + nicotinamide + palmitoylethanolamide + oleoylethanolamide increases 1-methylnicotinamide in humans.
“Plasma 1-methylnicotinamide, PEA, and OEA concentrations increased after supplement intake (P < .05).”
Human trialplasmamalesn = 5
Nutrition research (New York, N.Y.)Oct 23, 2024